Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial

被引：0
|
作者：
Jonas Wallström
Kjell Geterud
Kimia Kohestani
Stephan E. Maier
Marianne Månsson
Carl-Gustaf Pihl
Andreas Socratous
Rebecka Arnsrud Godtman
Mikael Hellström
Jonas Hugosson
机构：
[1] University of Gothenburg,Department of Radiology, Institute of Clinical Sciences, Sahlgrenska Academy
[2] Region Västra Götaland,Department of Radiology
[3] Sahlgrenska University Hospital,Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy
[4] University of Gothenburg,Department of Urology
[5] Region Västra Götaland,Department of Pathology, Institute of Biomedicine, Sahlgrenska Academy
[6] Sahlgrenska University Hospital,undefined
[7] University of Gothenburg,undefined
来源：
European Radiology | 2021年 / 31卷
关键词：
Multiparametric magnetic resonance imaging; Prostatic neoplasms; Early detection of cancer; Contrast media;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：8692 / 8702
页数：10
相关论文
共 50 条
  • [41] Multiparametric MRI-Based Radiomics for Prostate Cancer Screening With PSA in 4-10 ng/mL to Reduce Unnecessary Biopsies
    Qi, Yafei
    Zhang, Shuaitong
    Wei, Jingwei
    Zhang, Gumuyang
    Lei, Jing
    Yan, Weigang
    Xiao, Yu
    Yan, Shuang
    Xue, Huadan
    Feng, Feng
    Sun, Hao
    Tian, Jie
    Jin, Zhengyu
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2020, 51 (06) : 1890 - 1899
  • [42] Reply to "Prostate Cancer Screening and Prostate MRI: Hypotheses Founded on Uncertain Evidence"
    Correia, Eduardo T. de Oliveira
    Purysko, Andrei S.
    Paranhos, Bruno Merz
    Shoag, Jonathan E.
    Padhani, Anwar R.
    Bittencourt, Leonardo K.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2024, 222 (05)
  • [43] Detecting recurrent prostate Cancer using multiparametric MRI, influence of PSA and Gleason grade
    Aradhana M. Venkatesan
    Eniola Mudairu-Dawodu
    Cihan Duran
    R. Jason Stafford
    Yuanqing Yan
    Wei Wei
    Vikas Kundra
    Cancer Imaging, 21
  • [44] Detecting recurrent prostate Cancer using multiparametric MRI, influence of PSA and Gleason grade
    Venkatesan, Aradhana M.
    Mudairu-Dawodu, Eniola
    Duran, Cihan
    Stafford, R. Jason
    Yan, Yuanqing
    Wei, Wei
    Kundra, Vikas
    CANCER IMAGING, 2021, 21 (01)
  • [45] Prostate Cancer and PSA Among Statin Users in the Finnish Prostate Cancer Screening Trial Editorial Comment
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2010, 184 (01): : 175 - 176
  • [46] Results of the second screening round of the Finnish prostate cancer screening trial
    Tammela, TL
    Määttänen, L
    Stenman, UH
    Rannikko, S
    Juusela, H
    Aro, J
    Hakama, M
    Auvinen, A
    JOURNAL OF UROLOGY, 2002, 167 (04): : 100 - 100
  • [47] False positive screening results in the finnish prostate cancer screening trial
    Kilpelaeinen, T.
    Tammela, T. L.
    Martikainen, P.
    Maeaetlaenen, L.
    Auvinen, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 199 - 199
  • [48] Cost-effectiveness analysis of prostate cancer screening and MRI
    Takahashi, Takeshi
    WORLD JOURNAL OF UROLOGY, 2024, 42 (01)
  • [49] MRI-Targeted or Standard Biopsy in Prostate Cancer Screening
    Eklund, Martin
    Jaderling, Fredrik
    Discacciati, Andrea
    Bergman, Martin
    Annerstedt, Magnus
    Aly, Markus
    Glaessgen, Axel
    Carlsson, Stefan
    Groenberg, Henrik
    Nordstroem, Tobias
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (10): : 908 - 920
  • [50] Key learning on the promise and limitations of MRI in prostate cancer screening
    Padhani, Anwar R.
    Godtman, Rebecka A.
    Schoots, Ivo G.
    EUROPEAN RADIOLOGY, 2024, 34 (09) : 6168 - 6174
12345